47th week of 2020 patent applcation highlights part 8 |
Patent application number | Title | Published |
20200360241 | DENTAL COMPOSITION WITH HIGH E-MODULUS | 2020-11-19 |
20200360242 | Oral Care Gel | 2020-11-19 |
20200360243 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | 2020-11-19 |
20200360244 | POLYUREA CAPSULES PREPARED WITH ALIPHATICISOCYANATES AND AMINES | 2020-11-19 |
20200360245 | Vesicles for delayed delivery of fragrance their preparation and use thereof | 2020-11-19 |
20200360246 | HYDROGEN PEROXIDE FORMULATIONS IN BARRIER LAYER FILMS WITH A SIOx LAYER" | 2020-11-19 |
20200360247 | WHITE ACTIVATED CHARCOAL TOOTH WHITENING COMPOUND | 2020-11-19 |
20200360248 | COSMETIC COMPOSITION CONTAINING A POLYMER COMPRISING A CARBOSILOXANE DENDRIMER UNIT | 2020-11-19 |
20200360249 | AN ANTIMICROBIAL COMPOSITION | 2020-11-19 |
20200360250 | TITANIUM OXIDE POWDER, AND DISPERSION AND COSMETIC USING SAME | 2020-11-19 |
20200360251 | METHOD OF SELECTING MILD SKIN CLEANSERS | 2020-11-19 |
20200360252 | A PERSONAL CARE COMPOSITION | 2020-11-19 |
20200360253 | Preservative System | 2020-11-19 |
20200360254 | CONDITIONER COMPOSITION COMPRISING A CHELANT | 2020-11-19 |
20200360255 | HAIR COSMETIC | 2020-11-19 |
20200360256 | HAIR COSMETIC | 2020-11-19 |
20200360257 | HAIR TREATMENT METHOD | 2020-11-19 |
20200360258 | METHODS FOR MODULATING PIGMENTATION BY ANGIOTENSIN-CONVERTING ENZYME 2 MODULATION | 2020-11-19 |
20200360259 | Method of Selecting Skin Treatment Regimens, Ingredients and Compositions | 2020-11-19 |
20200360260 | TOPICAL COMPOSITION COMPRISING ANTIMICROBIAL LIPID | 2020-11-19 |
20200360261 | FUNCTIONAL POLYSACCHARIDE PARTICLE | 2020-11-19 |
20200360262 | HAIR COSMETIC | 2020-11-19 |
20200360263 | LIQUID COSMETIC | 2020-11-19 |
20200360264 | COMPOSITIONS COMPRISING AT LEAST ONE ACRYLIC POLYMER AND AT LEAST ONE INSOLUBLE ORGANIC SCREENING AGENT | 2020-11-19 |
20200360265 | Pumping Type Toothpaste Composition | 2020-11-19 |
20200360266 | A HAIR CARE COMPOSITION COMPRISING SILK FIBROIN | 2020-11-19 |
20200360267 | THERAPEUTIC METHODS FOR THE TREATMENT OF DIABETES AND RELATED CONDITIONS FOR PATIENTS WITH HIGH BASELINE HbA1c | 2020-11-19 |
20200360268 | INJECTABLE PHARMACEUTICAL COMPOSITION CONTAINING MELOXICAM, AND PREPARATION METHOD THEREFOR | 2020-11-19 |
20200360269 | CHARGE-SWITCHABLE POLYMERIC DEPOT FOR GLUCOSE-TRIGGERED INSULIN DELIVERY WITH ULTRAFAST RESPONSE | 2020-11-19 |
20200360270 | IMPLANTABLE CELLULAR AND BIOTHERAPEUTIC AGENT DELIVERY CANISTER | 2020-11-19 |
20200360271 | Methods and Compositions for Treating a Renal Disease Condition in a Subject | 2020-11-19 |
20200360272 | EQUINE DIETARY SUPPLEMENT | 2020-11-19 |
20200360273 | TREATMENT OF NOCTURNAL SYMPTOMS AND MORNING AKINESIA IN SUBJECTS WITH PARKINSON'S DISEASE | 2020-11-19 |
20200360274 | POWDER PREPARATION FOR NASAL ADMINISTRATION | 2020-11-19 |
20200360275 | INHALABLE IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | 2020-11-19 |
20200360276 | INHALABLE IMATINIB METABOLITE FORMULATIONS, MANUFACTURE, AND USES THEREOF | 2020-11-19 |
20200360277 | INHALABLE FORMULATIONS OF IMATINIB, IMATINIB METABOLITES, IMATINIB SALTS, THEIR MANUFACTURE, AND USES THEREOF | 2020-11-19 |
20200360278 | PROCESS FOR PREPARING A DRY POWDER FORMULATION COMPRISING AN ANTICHOLINERGIC, A CORTICOSTEROID AND A BETA-ADRENERGIC | 2020-11-19 |
20200360279 | NEBULIZED IMATINIB FORMULATIONS, MANUFACTURE, AND USES THEREOF | 2020-11-19 |
20200360280 | Unit Aerosol Doses For Anticoagulation | 2020-11-19 |
20200360281 | A THERMO-RESPONSIVE HYDROGEL FOR INTRATUMORAL ADMINISTRATION AS A TREATMENT IN SOLID TUMOR CANCERS | 2020-11-19 |
20200360282 | GEL FOR TREATING PERIOCULAR AND/OR ORBITAL PATHOLOGIES AND CONDITIONS | 2020-11-19 |
20200360283 | COMPOSITION AND METHOD FOR VANCOMYCIN ORAL LIQUID | 2020-11-19 |
20200360284 | FULVESTRANT FORMULATIONS AND METHODS OF THEIR USE | 2020-11-19 |
20200360285 | O/W-EMULSIONS COMPRISING SEMIFLUORINATED ALKANES | 2020-11-19 |
20200360286 | SELF-EMULSIFYING CANNABIDIOL FORMULATIONS | 2020-11-19 |
20200360287 | PHARMACEUTICAL COMPOSITIONS CONTAINING MIXED POLYMERIC MICELLES | 2020-11-19 |
20200360288 | METHOD AND DEVICES FOR DELIVERING THERAPEUTICS BY ORAL, RESPIRATORY, MUCOSAL, TRANSDERMAL ROUTES | 2020-11-19 |
20200360289 | FREEZE-DRIED PRODUCT AND GAS-FILLED MICROVESICLES SUSPENSION | 2020-11-19 |
20200360290 | ORAL COMPOSITIONS AND THE PREPARATION METHODS THEREOF | 2020-11-19 |
20200360291 | SOFT DUAL CHAMBERED LIQUID-GEL CAPSULE AND METHOD TO DELIVER SUBLINGUAL AND INGESTIBLE CANNABIS COMPOSITIONS | 2020-11-19 |
20200360292 | OIL-SOLUBLE DRUG CONTAINING COMPOSITIONS AND METHODS OF USE THEREOF | 2020-11-19 |
20200360293 | PACKAGED MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED STABILITY | 2020-11-19 |
20200360294 | Nanoparticle Compositions and Methods for Synthesis Thereof | 2020-11-19 |
20200360295 | Enzymatically Cleavable Self-Assembled Nanoparticles for Morphogen Delivery | 2020-11-19 |
20200360296 | NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY | 2020-11-19 |
20200360297 | Polymer-Encapsulated Viral Vectors for Genetic Therapy | 2020-11-19 |
20200360298 | COLD SORE TREATMENT FORMULATION AND RELATED METHOD OF APPLICATION-LIQUID PATCH FOR TREATMENT OF VIRAL LESIONS | 2020-11-19 |
20200360299 | TREATMENT OF FRAGILE X SYDROME WITH CANNABIDIOL | 2020-11-19 |
20200360300 | Suppression of Cytokine Release and Cytokine Storm | 2020-11-19 |
20200360301 | METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING TISSUE CALCIFICATION | 2020-11-19 |
20200360302 | TREATMENT OF LEIGH SYNDROME AND LEIGH-LIKE SYNDROME WITH TOCOTRIENOL QUINONES | 2020-11-19 |
20200360303 | METHOD FOR TREATING HYPERHIDROSIS | 2020-11-19 |
20200360304 | BETA-2 SELECTIVE ADRENERGIC RECEPTOR AGONISTS | 2020-11-19 |
20200360305 | USE OF TRIETHYLENETETRAMINE (TETA) FOR THE THERAPEUTIC INDUCTION OF AUTOPHAGY | 2020-11-19 |
20200360306 | USE OF CO-CRYSTALS OF TRAMADOL AND CELECOXIB FOR TREATING PAIN WHILE REDUCING THE ABUSE LIABILITY OF TRAMADOL | 2020-11-19 |
20200360307 | PHARMACOLOGICAL PROPHYLACTICS AGAINST STRESS-INDUCED AFFECTIVE DISORDERS IN FEMALES | 2020-11-19 |
20200360308 | KETAMINE FORMULATION FOR SUBCUTANEOUS INJECTION | 2020-11-19 |
20200360309 | COMPOSITIONS COMPRISING EPHEDRINE OR AN EPHEDRINE SALT AND METHODS OF MAKING AND USING SAME | 2020-11-19 |
20200360310 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2020-11-19 |
20200360311 | USE OF 3-METHYLMETHCATHINONE | 2020-11-19 |
20200360312 | COMPOSITIONS AND METHODS FOR MONITORING THE TREATMENT OF BREAST DISORDERS | 2020-11-19 |
20200360313 | S-ALKYLISOTHIOURONIUM DERIVATIVES FOR TREATING UTERINE HYPERCONTRACTILITY DISORDERS | 2020-11-19 |
20200360314 | METHODS AND COMPOSITIONS FOR TREATMENT OF PAIN USING CAPSAICIN | 2020-11-19 |
20200360315 | COMPOUND FOR USE IN THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES | 2020-11-19 |
20200360316 | COMBINATION THERAPY USING ACAMPROSATE AND D-CYCLOSERINE | 2020-11-19 |
20200360317 | CARBOXYLIC ACIDS FOR TREATING/PREVENTING A SKIN DISEASE | 2020-11-19 |
20200360318 | COMPOSITIONS AND METHODS FOR INCREASING THE POLLINATION PERFORMANCE OF BEES | 2020-11-19 |
20200360319 | GAMMA-HYDROXYBUTYRATE COMPOSITIONS HAVING IMPROVED PHARMACOKINETICS IN THE FED STATE | 2020-11-19 |
20200360320 | PHARMACEUTICAL COMPOSITION OF A WEAK ACID DRUG AND METHODS OF ADMINISTRATION | 2020-11-19 |
20200360321 | BENZOIC ACID OR A SALT AND DERIVATIVE THEREOF FOR USE IN PREVENTING OR TREATING DEPRESSION | 2020-11-19 |
20200360322 | FORMULATIONS AND DOSAGE FORMS FOR ENHANCING PERFORMANCE OR RECOVERY FROM STRESS | 2020-11-19 |
20200360323 | PREVENTION, TREATMENT AND REVERSAL OF DISEASE USING THERAPEUTICALLY EFFECTIVE AMOUNTS OF DICARBOXYLIC ACID COMPOUNDS | 2020-11-19 |
20200360324 | Compounds and Dosage Regimen for Use in the Prevention or Treatment of Chronic Inflammatory and/or Autoimmune Diseases | 2020-11-19 |
20200360325 | TOPICAL ANTI-INFLAMMATORY COMPOSITIONS | 2020-11-19 |
20200360326 | Aqueous Liquid Composition Containing 2-Amino-3-(4-Bromobenzoyl)Phenylacetic Acid | 2020-11-19 |
20200360327 | USE OF N-ACETYLCYSTEINE TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS | 2020-11-19 |
20200360328 | COMPOSITIONS AND METHODS FOR TREATING CANCER | 2020-11-19 |
20200360329 | METHODS FOR TREATING FAMILIAL ADENOMATOUS POLYPOSIS | 2020-11-19 |
20200360330 | COMPOSITIONS AND METHODS FOR TREATING AND/OR PREVENTING CARDIOVASCULAR DISEASE | 2020-11-19 |
20200360331 | COMPOSITIONS COMPRISING 15-HEPE AND/OR 15-HETrE AND METHODS OF TREATING OR PREVENTING CARDIOMETABOLIC DISEASE, METABOLIC SYNDROME, AND/OR RELATED DISEASES | 2020-11-19 |
20200360332 | COMPOUND FOR USE IN THE INCREASING OF MENTAL CAPACITY | 2020-11-19 |
20200360333 | MEANS FOR PROTECTING METHIONINE HYDROXY ANALOG FROM RUMEN DEGRADATION | 2020-11-19 |
20200360334 | New Uses of Lipophenolic Compounds | 2020-11-19 |
20200360335 | STABLE PHARMACEUTICAL COMPOSITION CONTAINING NON-STEROIDAL ANTI-INFLAMMATORY DRUG DERIVATIVE | 2020-11-19 |
20200360336 | USE OF CANNABIDIOL IN PREPARATION OF DRUGS FOR RESISTING AGAINST INFLUENZA | 2020-11-19 |
20200360337 | APPARATUSES, METHODS AND SYSTEMS FOR EXTRACTION, ISOLATION AND CONVERSION OF VARIOUS CANNABINOIDS, AND MODIFICATIONS OF WHOLE-PLANT HEMP EXTRACTS THEREWITH | 2020-11-19 |
20200360338 | METHOD FOR ACTIVATING ENERGY METABOLISM IN MUSCLE CELLS BY ADMINISTERING TO HUMAN BEINGS AT LEAST ONE ACTIVE SUBSTANCE COMPRISING METHOXYFLAVONE | 2020-11-19 |
20200360339 | FORMULATION BASED ON VITAMIN E OR AN ESTER THEREOF FOR TREATING BACTERIAL AND FUNGAL BIOFILMS | 2020-11-19 |
20200360340 | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CONDITIONS | 2020-11-19 |